Zheng Qiao, Pan Lihong, Ji Yong
Key Laboratory of Cardiovascular and Cerebrovascular Medicine, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
J Biomed Res. 2019 Aug 30;34(2):94-102. doi: 10.7555/JBR.33.20190071.
Hydrogen sulfide (H S) is an important messenger for its strong anti-inflammatory effects, which may be involved in multiple cardiovascular diseases. In our previous study, we revealed that H S attenuated diabetes-accelerated atherosclerosis through suppressing oxidative stress. Here we report that GYY4137, a H S donor, reduced the plaque formation of aortic roots and the levels of both intercellular cell adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1) in diabetes-accelerated atherosclerotic cells and mouse models. The inflammatory factors of TNF-α, IL-1β, IL-6, and MCP1 were also significantly reduced by GYY4137. Mechanically, GYY4137 suppressed the activation of pyrin domain containing protein 3 (NLRP3) inflammasome in diabetes-accelerated atherosclerosis conditions. Upon knockdown of NLRP3, the increase of ICAM1 and VCAM1 caused by high glucose and oxLDL could be reversed, indicating that H S protected the endothelium by inhibiting the activity of NLRP3 inflammasome. In conclusion, our study indicates that GYY4137 effectively protects against the development of diabetes-accelerated atherosclerosis by inhibiting inflammasome activation.
硫化氢(H₂S)作为一种重要的信使分子,具有强大的抗炎作用,可能参与多种心血管疾病的发生发展。在我们之前的研究中,我们发现H₂S通过抑制氧化应激减轻糖尿病加速的动脉粥样硬化。在此,我们报告H₂S供体GYY4137可减少糖尿病加速动脉粥样硬化细胞和小鼠模型中主动脉根部斑块的形成以及细胞间黏附分子1(ICAM1)和血管细胞黏附分子1(VCAM1)的水平。GYY4137还能显著降低肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)和单核细胞趋化蛋白1(MCP1)等炎症因子的水平。机制上,在糖尿病加速动脉粥样硬化的条件下,GYY4137可抑制含pyrin结构域蛋白3(NLRP3)炎性小体的激活。敲低NLRP3后,高糖和氧化型低密度脂蛋白(oxLDL)引起的ICAM1和VCAM1的增加可被逆转,这表明H₂S通过抑制NLRP3炎性小体的活性来保护内皮细胞。总之,我们的研究表明GYY4137通过抑制炎性小体激活有效地预防糖尿病加速的动脉粥样硬化的发展。